Article
Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations.
American journal of obstetrics and gynecology - 1 Nov 2021
Smith Maria J, Gerber Deanna, Olsen Anne, Khouri Olivia R, Wang Yuyan, Liu Mengling, Smith Julia, Pothuri Bhavana
Abstract excerpt
BACKGROUND: In women with BRCA mutations, risk-reducing bilateral salpingo-oophorectomy has been shown to decrease gynecologic cancer-specific and overall mortality. The National Comprehensive Cancer Network recommends that patients with BRCA mutations undergo risk-reducing bilateral salpingo-oophorectomy between the ages of 35 and 40 years for BRCA1 mutation carriers and between the ages of 40 and 45 years for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
